CY1122081T1 - Διαλυματα τα οποια περιλαμβανουν πολυαιθυλενογλυκολη και ηλεκτρολυτες - Google Patents
Διαλυματα τα οποια περιλαμβανουν πολυαιθυλενογλυκολη και ηλεκτρολυτεςInfo
- Publication number
- CY1122081T1 CY1122081T1 CY20191100931T CY191100931T CY1122081T1 CY 1122081 T1 CY1122081 T1 CY 1122081T1 CY 20191100931 T CY20191100931 T CY 20191100931T CY 191100931 T CY191100931 T CY 191100931T CY 1122081 T1 CY1122081 T1 CY 1122081T1
- Authority
- CY
- Cyprus
- Prior art keywords
- polyethylene glycol
- solution
- amount
- electrolytes
- solutions containing
- Prior art date
Links
- 239000002202 Polyethylene glycol Substances 0.000 title abstract 3
- 229920001223 polyethylene glycol Polymers 0.000 title abstract 3
- 239000003792 electrolyte Substances 0.000 title 1
- 239000000243 solution Substances 0.000 abstract 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 206010010774 Constipation Diseases 0.000 abstract 1
- 206010056325 Faecaloma Diseases 0.000 abstract 1
- 208000008415 Fecal Impaction Diseases 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 238000010790 dilution Methods 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 239000001103 potassium chloride Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η εφεύρεση παρέχει ένα διάλυμα σε νερό το οποίο περιλαμβάνει τα ακόλουθα συστατικά στις ακόλουθες συγκεντρώσεις: (a) Ν x (70 έως 130) g/L πολυαιθυλενογλυκόλης (PEG) η οποία έχει ένα μέσο μοριακό βάρος από 2500 έως 4500˙ (b) Ν x (1,6 έως 4,0) g/L χλωριούχου νατρίου˙ (c) Ν x (0,2 έως 0,6) g/L χλωριούχου καλίου˙ (d) Ν x (0,6 έως 2,2) g/L όξινου ανθρακικού νατρίου˙ (e) Ν x μια ποσότητα συντηρητικού˙ (f) προαιρετικά Ν x μία ποσότητα αρωματικής ουσίας˙ και (g) προαιρετικά Ν x μία ποσότητα γλυκαντικού όπου Ν είναι στο εύρος από 2 έως 8. Το διάλυμα είναι ένα συμπύκνωμα για αραίωση. Κατά τη χρήση αραιώνεται Ν-πλάσιες φορές με νερό για να παράσχει ένα διάλυμα για χορήγηση σε ένα υποκείμενο για την αντιμετώπιση δυσκοιλιότητας ή ενσφήνωσης κοπράνων. Παρέχονται επίσης διαλύματα, κυτία, μοναδιαίες δόσεις και μέθοδοι που περιλαμβάνουν ή χρησιμοποιούν τα διαλύματα.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0913295.2A GB0913295D0 (en) | 2009-07-30 | 2009-07-30 | Improvements in and relating to pharmaceutical compositions |
| PCT/GB2010/001455 WO2011012866A1 (en) | 2009-07-30 | 2010-07-30 | Solutions comprising polyethylene glycol and electrolytes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1122081T1 true CY1122081T1 (el) | 2020-11-25 |
Family
ID=41067102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100931T CY1122081T1 (el) | 2009-07-30 | 2019-09-05 | Διαλυματα τα οποια περιλαμβανουν πολυαιθυλενογλυκολη και ηλεκτρολυτες |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US20120135090A1 (el) |
| EP (1) | EP2459218B1 (el) |
| JP (1) | JP5708943B2 (el) |
| KR (1) | KR101868834B1 (el) |
| CN (2) | CN103932979B (el) |
| AR (2) | AR077347A1 (el) |
| AT (1) | AT12341U1 (el) |
| AU (1) | AU2010277354B2 (el) |
| BE (1) | BE1019753A5 (el) |
| BR (1) | BR112012001899B8 (el) |
| CA (1) | CA2769247C (el) |
| CY (1) | CY1122081T1 (el) |
| DK (1) | DK2459218T3 (el) |
| EA (1) | EA025112B1 (el) |
| ES (1) | ES2388095B1 (el) |
| FR (1) | FR2948569B3 (el) |
| GB (3) | GB0913295D0 (el) |
| HK (1) | HK1150430A1 (el) |
| HR (1) | HRP20191465T1 (el) |
| HU (1) | HUE046705T2 (el) |
| IT (1) | IT1402374B1 (el) |
| LT (1) | LT2459218T (el) |
| MX (1) | MX337114B (el) |
| NL (1) | NL2005176C2 (el) |
| NZ (1) | NZ597822A (el) |
| PL (1) | PL2459218T3 (el) |
| PT (1) | PT2459218T (el) |
| RS (1) | RS59294B1 (el) |
| SI (1) | SI2459218T1 (el) |
| TW (1) | TWI478716B (el) |
| WO (1) | WO2011012866A1 (el) |
| ZA (1) | ZA201200661B (el) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201200637D0 (en) | 2012-01-13 | 2012-02-29 | Norgine Bv | Improvements in and relating to compositions |
| KR101852502B1 (ko) * | 2011-01-31 | 2018-04-26 | 노어긴 비.브이. | 조성물에 관한 개선 |
| TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
| CN102600201B (zh) * | 2012-02-07 | 2014-07-16 | 舒泰神（北京）生物制药股份有限公司 | 用于通便和清肠的药物组合物及其制备方法 |
| US20140065076A1 (en) * | 2012-08-30 | 2014-03-06 | Otsuka Pharmaceutical Co. Ltd. | Container with concentrated substance and method of using the same |
| KR20170098980A (ko) | 2012-09-11 | 2017-08-30 | 노어긴 비.브이. | Peg 및 아스코르베이트를 포함하는 조성물 |
| EA201992382A3 (ru) | 2013-03-15 | 2020-05-31 | Брейнтри Лабораторис, Инк. | Пероральная таблетированная фармацевтическая композиция двойного применения на основе сульфатных солей и способы ее применения |
| CN112494511A (zh) * | 2020-12-06 | 2021-03-16 | 天津康哲医药科技发展有限公司 | 一种聚乙二醇钠钾口服药物制剂的制备 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6196786A (en) * | 1985-08-01 | 1987-03-05 | Braintree Laboratories Inc. | Low-sodium laxative and lavage formulation |
| JP2596764B2 (ja) | 1987-11-18 | 1997-04-02 | ルセル森下株式会社 | 腸管洗浄液剤 |
| US5378470A (en) | 1989-07-25 | 1995-01-03 | Henning Berlin Gmbh | Rectally administered pharmaceutical preparation |
| AU5679794A (en) | 1992-11-24 | 1994-06-22 | Block Drug Company Inc., The | Pharmaceutical compositions for use in gastrointestinal washes |
| RU2111741C1 (ru) * | 1994-10-27 | 1998-05-27 | Государственный научный центр колопроктологии Министерства здравоохранения и медицинской промышленности Российской Федерации | Вещество для общего промывания желудочно-кишечного тракта |
| US5710183A (en) | 1995-07-14 | 1998-01-20 | Halow; George M. | Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent |
| US6162464A (en) | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
| US6071523A (en) | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
| US6048901A (en) | 1999-04-20 | 2000-04-11 | Braintree Laboratories, Inc. | Method of reducing intestinal gas, cramping and anorectal irritation |
| IL137275A0 (en) | 2000-07-12 | 2001-07-24 | Yosefus Azaria | Pharmaceutical composition for the treatment of anal fissures |
| ATE477790T1 (de) | 2001-10-29 | 2010-09-15 | Ajinomoto Kk | Lösung zur darmreinigung |
| US6946149B2 (en) | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
| US7291324B2 (en) * | 2002-10-22 | 2007-11-06 | Braintree Laboratories Inc. | Method of bowel cleansing |
| GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
| US7332184B2 (en) | 2003-03-28 | 2008-02-19 | Queen's University At Kingston | Colonic cleansing composition and method |
| US20050152989A1 (en) | 2003-07-09 | 2005-07-14 | Braintree Laboratories, Inc. | Method for treating irritable bowel syndrome |
| WO2005049049A1 (en) * | 2003-11-17 | 2005-06-02 | Braintree Laboratories, Inc. | Therapeutic peg solution concentrate |
| GB0409104D0 (en) * | 2004-04-23 | 2004-05-26 | Norgine Europe Bv | Compressed pharmaceutical compositions |
| CA2607250C (en) * | 2005-05-06 | 2012-11-06 | Salix Pharmaceuticals, Inc. | Polyethylene glycol colonic purgative composition |
| US20070082061A1 (en) * | 2005-10-07 | 2007-04-12 | Nelson Ayala | Reduction of saltiness with sweeteners |
| DE102006001199A1 (de) | 2006-01-10 | 2007-07-12 | Medicoforum Gmbh | Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans |
| ES2278537B1 (es) | 2006-01-30 | 2008-09-16 | Laboratorios Casen-Fleet, S.L. | Procedimiento de fabricacion de una solucion a base de polietilenglicol con electrolitos, producto obtenido y uso. |
| CN1850112B (zh) * | 2006-03-06 | 2011-06-29 | 北京圣永制药有限公司 | 聚乙二醇-电解质口服溶液 |
| WO2009036906A1 (de) * | 2007-09-22 | 2009-03-26 | Bayer Consumer Care Ag | Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation |
| US8362083B2 (en) * | 2008-01-15 | 2013-01-29 | C.B. Fleet Company Inc. | Taste-masked docusate compositions |
-
2009
- 2009-07-30 GB GBGB0913295.2A patent/GB0913295D0/en not_active Ceased
-
2010
- 2010-07-30 PT PT10739973T patent/PT2459218T/pt unknown
- 2010-07-30 CA CA2769247A patent/CA2769247C/en active Active
- 2010-07-30 KR KR1020127005284A patent/KR101868834B1/ko active IP Right Grant
- 2010-07-30 AR ARP100102787A patent/AR077347A1/es not_active Application Discontinuation
- 2010-07-30 DK DK10739973.5T patent/DK2459218T3/da active
- 2010-07-30 US US13/387,791 patent/US20120135090A1/en not_active Abandoned
- 2010-07-30 GB GB1108383.9A patent/GB2478076B/en active Active
- 2010-07-30 NL NL2005176A patent/NL2005176C2/en active
- 2010-07-30 MX MX2012001108A patent/MX337114B/es active IP Right Grant
- 2010-07-30 IT ITMI2010A001436A patent/IT1402374B1/it active
- 2010-07-30 HU HUE10739973A patent/HUE046705T2/hu unknown
- 2010-07-30 BE BE2010/0471A patent/BE1019753A5/fr active
- 2010-07-30 CN CN201410088148.5A patent/CN103932979B/zh active Active
- 2010-07-30 SI SI201031928T patent/SI2459218T1/sl unknown
- 2010-07-30 BR BR112012001899A patent/BR112012001899B8/pt active IP Right Grant
- 2010-07-30 JP JP2012522244A patent/JP5708943B2/ja active Active
- 2010-07-30 RS RSP20191169 patent/RS59294B1/sr unknown
- 2010-07-30 EA EA201200220A patent/EA025112B1/ru unknown
- 2010-07-30 LT LTEP10739973.5T patent/LT2459218T/lt unknown
- 2010-07-30 CN CN2010800327206A patent/CN102548580A/zh active Pending
- 2010-07-30 AU AU2010277354A patent/AU2010277354B2/en active Active
- 2010-07-30 GB GB201012903A patent/GB2472324C/en active Active
- 2010-07-30 EP EP10739973.5A patent/EP2459218B1/en active Active
- 2010-07-30 PL PL10739973T patent/PL2459218T3/pl unknown
- 2010-07-30 FR FR1056333A patent/FR2948569B3/fr not_active Expired - Lifetime
- 2010-07-30 AT AT0075910U patent/AT12341U1/de not_active IP Right Cessation
- 2010-07-30 NZ NZ597822A patent/NZ597822A/xx unknown
- 2010-07-30 ES ES201090080A patent/ES2388095B1/es active Active
- 2010-07-30 TW TW099125291A patent/TWI478716B/zh active
- 2010-07-30 WO PCT/GB2010/001455 patent/WO2011012866A1/en active Application Filing
-
2011
- 2011-05-16 HK HK11104772.3A patent/HK1150430A1/xx unknown
-
2012
- 2012-01-26 ZA ZA2012/00661A patent/ZA201200661B/en unknown
-
2014
- 2014-01-28 US US14/166,716 patent/US9468686B2/en active Active
-
2019
- 2019-08-13 HR HRP20191465 patent/HRP20191465T1/hr unknown
- 2019-09-05 CY CY20191100931T patent/CY1122081T1/el unknown
- 2019-12-18 AR ARP190103730A patent/AR117718A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122081T1 (el) | Διαλυματα τα οποια περιλαμβανουν πολυαιθυλενογλυκολη και ηλεκτρολυτες | |
| CY1122187T1 (el) | Αντιγονικη συνθεση μυκοβακτηριου | |
| CY1115565T1 (el) | Μεθοδος και συνθεση για την αγωγη της οφθαλμικης υπερτασεως και του γλαυκωματος | |
| MX2009011642A (es) | Compuestos y metodos para potenciar la solubilidad de florfenicol y antibioticos estructuralmente relacionados utilizando ciclodextrinas. | |
| EA201200153A1 (ru) | Сухая композиция для смешивания с водой (варианты), раствор для очищения кишечника на ее основе, водный раствор, набор, способ очищения толстой кишки | |
| CR20120649A (es) | Compuestos, composiciones de tioacetato y métodos de uso | |
| CY1118321T1 (el) | Συστημα διαλυτων για βελτιωση της διαλυτοτητας των φαρμακευτικων παραγοντων | |
| PE20170183A1 (es) | Composiciones estables de yodo no en complejo y metodos de uso | |
| CY1110873T1 (el) | Σταθεροποιημενα σκευασματα αντισωματων anti-rsv, υγρης μορφης | |
| CY1112813T1 (el) | 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων | |
| EA201170508A1 (ru) | Производные 1-амино-2-циклобутилэтилбороновой кислоты | |
| CO6382164A2 (es) | Solucion acuosa para la preservacion de tejidos y organos | |
| BR112013033577A2 (pt) | membrana inflável para utilização em formação de imagem tridimensional | |
| CY1115485T1 (el) | Χρησιμοποιηση αμισουλπριδης για τη θεραπεια μετεγχειρητικης ναυτιας και εμετου | |
| CY1125033T1 (el) | Σκευασμα μεθοτρεξατης | |
| TR200806298A2 (tr) | Farmasötik formülasyon | |
| EA201190285A1 (ru) | Иммуногенные композиции, имеющие низкую концентрацию хлорида натрия | |
| ATE543492T1 (de) | Behandlung von lungenkrebs | |
| CY1116831T1 (el) | ΧΡΗΣΗ 24-norUDCA | |
| ES2509966T1 (es) | Composiciones que tienen concentraciones incrementadas de carboximetilcelulosa | |
| EA201691066A1 (ru) | Растворы для повышения стабильности и срок годности раствора для консервирования органов и тканей | |
| AR091977A1 (es) | El uso de antitrombina en la oxigenacion de membranas extracorporeas | |
| CY1118570T1 (el) | Νεα συνθεση αλφαιντανυλης για την αγωγη του οξεος πονου | |
| EA201390925A1 (ru) | Производные санглиферина и способы их получения | |
| EA201490127A1 (ru) | Офтальмологический раствор, содержащий гиалуроновую кислоту или ее соль и пропиленгликоль |